Inamed's 2.5 Mil. Share Secondary Offering Expected To Net $60 Mil.
This article was originally published in The Gray Sheet
Executive Summary
Proceeds from Inamed's secondary 2.5 mil. share stock offering will go toward significantly reducing the $155 mil. in outstanding debt under the company's bridge loan facility.
You may also be interested in...
Inamed To Finalize $142 Mil. Collagen Aesthetics Acquisition By Oct. 1
Inamed is looking to build a $225 mil. global plastic and aesthetic surgery device business through the acquisition of Palo Alto, California-based Collagen Aesthetics.
ATS Licenses Tissue Technology To Inamed For Cosmetic Applications
Advanced Tissue Sciences and Inamed expect to market a tissue-engineered product for healing skin following laser peel procedures by the end of the year, under a strategic alliance announced May 12.
Small Sterilization Companies Poised To Meet EtO Emissions Goals On Time
Small sterilizers told Medtech Insight that they were ready for the EPA’s controversial EtO emissions rule, while community advocates expressed concerns.